Smishing Incident Response Guide for Controlled Substance Prescription Records

Contain Identity Access Immediately

Act within minutes to stop misuse of prescribing credentials and protect Electronic protected health information (ePHI). Treat any SMS-based lure or link click as a potential account compromise until proven otherwise.

• Isolate the affected phone: enable airplane mode, remove unknown profiles, and place the device under mobile device management (MDM) quarantine for imaging and triage.
• Disable e-prescribing for controlled substances on impacted prescriber accounts; immediately revoke signing tokens, certificates, or app approvals tied to Two-factor authentication.
• Force password resets and kill active sessions across the EHR, e-prescribing, identity provider, email, and cloud apps; rotate API keys and push-notification tokens.
• Lock down identity stores: remove risky devices, invalidate SMS one-time codes, and require step-up verification before any restoration of access.
• Place a legal/eDiscovery hold on relevant records; capture screenshots of smishing texts, short links, and callback numbers as evidence.
• Notify the privacy and security officers, pharmacy operations, and compliance leadership; follow contingency workflows for prescribing consistent with federal and state law.

Investigate Device and Authentication Activity

Establish a verified timeline of what the attacker did, on which device, and with which identity. Prioritize signs of unauthorized prescribing or data access.

What to collect

• EHR, e-prescribing, and identity provider logs: logins, device fingerprints, geolocation, and failed/successful Two-factor authentication events.
• EPCS audit data: authorization attempts, prescription creation, cancel, and change messages; mapping to the prescriber’s DEA registration number.
• Mobile telemetry: unknown apps, configuration profiles, jailbreak/root indicators, malicious SMS URLs, and SIM-swap or call-forwarding changes.

How to analyze

• Correlate off-hours access, new IP ranges, or “impossible travel” with prescription activity.
• Review any edits to EPCS permissions, identity proofing status, and token enrollments for the prescriber.
• Compare pharmacy fill data to detect anomalous quantities, high-risk combinations, or unusual dispensing locations.

Device triage actions

• Export the SMS thread and embedded URLs; submit to security tooling for verdicts without clicking unknown links.
• Remove malicious profiles, reset network settings, and re-enroll the device; if compromise persists, factory-reset and rebuild from known-good backups.
• Contact the carrier to verify no SIM-swap, call-forward, or text interception occurred.

Identify Broader Campaign Activity

Determine whether the message is part of a coordinated smishing run targeting multiple clinicians, pharmacies, or departments. Share indicators and clamp down quickly.

• Aggregate indicators of compromise: sender numbers, lures, short domains, landing pages, and callback IVR scripts.
• Search enterprise email/SMS gateways and EDR/MDM for the same patterns; auto-quarantine matching artifacts.
• Brief pharmacy partners to challenge suspect orders and verify prescriber identity out-of-band using known contact paths.
• Encourage staff to forward spam texts to 7726 (SPAM) and report internally so you can tune filtering and user education.

Comply with Controlled Substance Prescription Record Requirements

Preserve complete, accurate, and tamper-evident controlled substance prescription records while the investigation proceeds. Align recordkeeping with federal rules and stricter state requirements.

Maintain complete prescription content

• Patient full name and address.
• Drug name, strength, dosage form, quantity prescribed, and directions for use.
• Date of issuance and, when applicable, authorized refills consistent with schedule limits.
• Prescriber name, address, and DEA registration number.
• Manual or electronic signature; for EPCS, include signing metadata and certificate or token identifiers.

Preserve audit trails and retention

• Retain e-prescribing logs, identity proofing records, logical access approvals, and authentication events.
• Maintain controlled substance prescription data transmission records and acknowledgments to demonstrate integrity and non-repudiation.
• Keep records for at least two years federally, or longer if state rules require; store backups offline and verify they are immutable.

Segregate and protect suspect records

• Flag possibly fraudulent prescriptions; restrict access to need-to-know teams and document chain of custody.
• Minimize exposure of ePHI during investigation; use redaction where practical.

Report Smishing Incidents Properly

Coordinate regulatory, patient, and law-enforcement notifications. Your obligations differ for data exposure versus diversion or loss of controlled substances.

HIPAA Breach Notification Rule

• Conduct a risk assessment to determine if ePHI was compromised (nature/extent of data, unauthorized person, whether data was actually acquired or viewed, and mitigation).
• If a reportable breach occurred, notify affected individuals without unreasonable delay and no later than 60 days after discovery.
• For incidents affecting 500 or more residents of a state or jurisdiction, notify HHS and prominent media within 60 days; maintain a breach log for smaller incidents and report annually.
• Ensure business associates notify covered entities timely so you can meet statutory deadlines.

Law enforcement and DEA considerations

• Report criminal activity to local or federal law enforcement as appropriate and preserve evidence on a litigation hold.
• If the event results in theft or significant loss of controlled substances (including fraudulent dispensing), notify DEA within one business day and file DEA Form 106 once facts are known.
• Follow state breach and diversion reporting rules, and notify boards of pharmacy/medicine and payers when required.

Operational communications

• Alert pharmacies to void or confirm impacted prescriptions using verified contact channels.
• Provide patients with clear remediation steps and monitoring resources when their data or therapy may be affected.

Follow Electronic Prescription Security Protocols

Harden EPCS controls to prevent replay, impersonation, and fraudulent orders. Re-issue trust only after thorough verification.

Identity proofing

• Perform high-assurance identity proofing for prescribers before granting EPCS access; re-proof after any suspected compromise.
• Document approvers, artifacts, and validity periods; review at credential renewal or role changes.

Strong authentication and signing

• Require Two-factor authentication to sign controlled substance prescriptions, using two of the following: knowledge (password/PIN), possession (hardware/software token), or inherence (biometric).
• Use hardware-backed keys where possible; promptly revoke lost or cloned authenticators and re-enroll only after identity proofing.

Secure data handling

• Encrypt controlled substance prescription data transmission end-to-end and encrypt ePHI at rest; apply digital signatures or message authentication to detect tampering.
• Retain complete, immutable audit logs for access, signing, and transmission events; continuously monitor for anomalies.

Access governance

• Enforce least privilege and segregation of duties for EPCS administration and auditing functions.
• Review access quarterly and on-demand after incidents; disable dormant accounts and stale tokens.

Implement Post-Incident Analysis and Reporting

Translate lessons learned into durable security and compliance improvements. Close the loop with leadership and frontline staff.

Root cause and corrective actions

• Document the attack path, impacted identities, prescriptions, and systems; quantify risk to ePHI and operations.
• Address specific control gaps: SMS filtering, URL rewriting, authenticator issuance, session lifetime, and monitoring rules.

Training and resilience

• Refresh smishing simulations and just-in-time education for prescribers and pharmacy staff.
• Update incident runbooks for device isolation, identity lockdown, and pharmacy verification procedures.

Testing and validation

• Run tabletop exercises involving clinical, pharmacy, compliance, and IT teams; track time-to-contain and time-to-notify.
• Validate backups, EPCS revocation/re-issuance flows, and end-to-end alerting from detection through escalation.

Conclusion

Rapid identity containment, thorough log-driven investigation, strict record preservation, and timely notifications are the pillars of a strong response. By reinforcing identity proofing, Two-factor authentication, and secure controlled substance prescription data transmission, you reduce risk to patients, prescribers, and your compliance posture.

FAQs

How should a smishing incident involving prescription records be contained?

Immediately quarantine the device, revoke EPCS signing tokens, force password resets and session kills across the EHR and identity provider, and suspend controlled substance e-prescribing for affected accounts. Preserve the SMS evidence and notify your privacy and security officers so HIPAA and diversion reporting workflows can start without delay.

What specific information must be included in controlled substance prescriptions?

Include the patient’s full name and address; drug name, strength, dosage form, quantity, and directions; date of issuance; prescriber name and address; the prescriber’s DEA registration number; and a manual or electronic signature. For EPCS, also retain signing metadata and related authorization logs.

How is electronic prescribing secured for controlled substances?

Prescribers undergo identity proofing before EPCS access, then use Two-factor authentication to sign. Systems protect Electronic protected health information (ePHI) with encryption in transit and at rest, apply digital signatures or message authentication to prescriptions, and maintain immutable audit logs covering access, signing, and controlled substance prescription data transmission.

How do you report theft or loss of controlled substances?

Notify DEA within one business day of discovering a theft or significant loss, then complete and submit DEA Form 106 once facts are confirmed. Also follow state reporting rules, notify law enforcement as appropriate, and retain all records and audit logs supporting the event and remediation steps.